Category:
Preclinical Research Services
CAS NO:
841301-32-4
Standard:
ChP,
Amenamevir (CAS: 1294657-88-1) is a novel oral antiviral agent developed for the treatment of herpes zoster. Its core synthesis involves specific heterocyclic coupling reactions to form the pyrimidine derivative structure with molecular formula C14H18N4O2.
Strictly contraindicated for patients with known hypersensitivity to amenamevir components. Requires storage under controlled conditions at 2°C–8°C to maintain chemical stability and potency during transport.